237 related articles for article (PubMed ID: 24632412)
1. Selective inhibition of class I but not class IIb histone deacetylases exerts cardiac protection from ischemia reperfusion.
Aune SE; Herr DJ; Mani SK; Menick DR
J Mol Cell Cardiol; 2014 Jul; 72():138-45. PubMed ID: 24632412
[TBL] [Abstract][Full Text] [Related]
2. How to Distinguish Between the Activity of HDAC1-3 and HDAC6 with Western Blot.
Beyer M; Kiweler N; Mahboobi S; Krämer OH
Methods Mol Biol; 2017; 1510():355-364. PubMed ID: 27761834
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological modulation of HDAC1 and HDAC6 in vivo in a zebrafish model: Therapeutic implications for Parkinson's disease.
Pinho BR; Reis SD; Guedes-Dias P; Leitão-Rocha A; Quintas C; Valentão P; Andrade PB; Santos MM; Oliveira JM
Pharmacol Res; 2016 Jan; 103():328-39. PubMed ID: 26657418
[TBL] [Abstract][Full Text] [Related]
4. Trichostatin A induces 5-lipoxygenase promoter activity and mRNA expression via inhibition of histone deacetylase 2 and 3.
Pufahl L; Katryniok C; Schnur N; Sorg BL; Metzner J; Grez M; Steinhilber D
J Cell Mol Med; 2012 Jul; 16(7):1461-73. PubMed ID: 21883892
[TBL] [Abstract][Full Text] [Related]
5. HDAC1 localizes to the mitochondria of cardiac myocytes and contributes to early cardiac reperfusion injury.
Herr DJ; Baarine M; Aune SE; Li X; Ball LE; Lemasters JJ; Beeson CC; Chou JC; Menick DR
J Mol Cell Cardiol; 2018 Jan; 114():309-319. PubMed ID: 29224834
[TBL] [Abstract][Full Text] [Related]
6. Targeted deletion of NF-kappaB p50 diminishes the cardioprotection of histone deacetylase inhibition.
Zhang LX; Zhao Y; Cheng G; Guo TL; Chin YE; Liu PY; Zhao TC
Am J Physiol Heart Circ Physiol; 2010 Jun; 298(6):H2154-63. PubMed ID: 20382965
[TBL] [Abstract][Full Text] [Related]
7. Trichostatin A attenuates oxidative stress-mediated myocardial injury through the FoxO3a signaling pathway.
Guo Y; Li Z; Shi C; Li J; Yao M; Chen X
Int J Mol Med; 2017 Oct; 40(4):999-1008. PubMed ID: 28849190
[TBL] [Abstract][Full Text] [Related]
8. Differential regulation of Bdnf expression in cortical neurons by class-selective histone deacetylase inhibitors.
Koppel I; Timmusk T
Neuropharmacology; 2013 Dec; 75():106-15. PubMed ID: 23916482
[TBL] [Abstract][Full Text] [Related]
9. Investigating the potential effects of selective histone deacetylase 6 inhibitor ACY1215 on infarct size in rats with cardiac ischemia-reperfusion injury.
Lin CF; Hsu KC; HuangFu WC; Lin TE; Huang HL; Pan SL
BMC Pharmacol Toxicol; 2020 Mar; 21(1):21. PubMed ID: 32178737
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury.
Zhao TC; Cheng G; Zhang LX; Tseng YT; Padbury JF
Cardiovasc Res; 2007 Dec; 76(3):473-81. PubMed ID: 17884027
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of class IIa histone deacetylase activity by gallic acid, sulforaphane, TMP269, and panobinostat.
Choi SY; Kee HJ; Jin L; Ryu Y; Sun S; Kim GR; Jeong MH
Biomed Pharmacother; 2018 May; 101():145-154. PubMed ID: 29482060
[TBL] [Abstract][Full Text] [Related]
12. Class II histone deacetylases require P/Q-type Ca
Urbano FJ; Bisagno V; Mahaffey S; Lee SH; Garcia-Rill E
Sci Rep; 2018 Sep; 8(1):13156. PubMed ID: 30177751
[TBL] [Abstract][Full Text] [Related]
13. Sirtinol abrogates late phase of cardiac ischemia preconditioning in rats.
Safari F; Shekarforoosh S; Hashemi T; Namvar Aghdash S; Fekri A; Safari F
J Physiol Sci; 2017 Jul; 67(4):515-522. PubMed ID: 27677982
[TBL] [Abstract][Full Text] [Related]
14. Suppression of Excessive Histone Deacetylases Activity in Diabetic Hearts Attenuates Myocardial Ischemia/Reperfusion Injury via Mitochondria Apoptosis Pathway.
Wu Y; Leng Y; Meng Q; Xue R; Zhao B; Zhan L; Xia Z
J Diabetes Res; 2017; 2017():8208065. PubMed ID: 28191472
[No Abstract] [Full Text] [Related]
15. Inhibition of histone deacetylase 6 improves long-term survival in a lethal septic model.
Li Y; Zhao T; Liu B; Halaweish I; Mazitschek R; Duan X; Alam HB
J Trauma Acute Care Surg; 2015 Feb; 78(2):378-85. PubMed ID: 25757125
[TBL] [Abstract][Full Text] [Related]
16. Fluid-electrolyte homeostasis requires histone deacetylase function.
Hyndman KA; Speed JS; Mendoza LD; Allan JM; Colson J; Sedaka R; Jin C; Jung HJ; El-Dahr S; Pollock DM; Pollock JS
JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32673289
[TBL] [Abstract][Full Text] [Related]
17. Isoform-Selective HDAC Inhibitor Mocetinostat (MGCD0103) Alleviates Myocardial Ischemia/Reperfusion Injury Via Mitochondrial Protection Through the HDACs/CREB/PGC-1α Signaling Pathway.
Wang K; Tang R; Wang S; Xiong Y; Wang W; Chen G; Zhang K; Li P; Tang YD
J Cardiovasc Pharmacol; 2022 Feb; 79(2):217-228. PubMed ID: 34983914
[TBL] [Abstract][Full Text] [Related]
18. Activation of Class I histone deacetylases contributes to mitochondrial dysfunction in cardiomyocytes with altered complex activities.
Lkhagva B; Kao YH; Lee TI; Lee TW; Cheng WL; Chen YJ
Epigenetics; 2018; 13(4):376-385. PubMed ID: 29613828
[TBL] [Abstract][Full Text] [Related]
19. Cardiac HDAC6 catalytic activity is induced in response to chronic hypertension.
Lemon DD; Horn TR; Cavasin MA; Jeong MY; Haubold KW; Long CS; Irwin DC; McCune SA; Chung E; Leinwand LA; McKinsey TA
J Mol Cell Cardiol; 2011 Jul; 51(1):41-50. PubMed ID: 21539845
[TBL] [Abstract][Full Text] [Related]
20. HDAC inhibition elicits myocardial protective effect through modulation of MKK3/Akt-1.
Zhao TC; Du J; Zhuang S; Liu P; Zhang LX
PLoS One; 2013; 8(6):e65474. PubMed ID: 23762381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
